Editorial Commentary
Sequential therapy with induction chemotherapy and chemoradiotherapy in pre-irradiated recurrent head and neck squamous cell carcinoma incorporating nab-paclitaxel—a commentary of the phase I trial of AFHX followed by concomitant FHX scheme
Translational Cancer Research
2023;
12
(4)
:692-696
.
(28 April 2023)
Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection?
Translational Cancer Research
2023;
12
(4)
:697-700
.
(28 April 2023)
Combining immunotherapy and radiotherapy in hepatocellular carcinoma: the importance of irradiated tumor burden and the possible role of a low dose radiotherapy induction strategy
Translational Cancer Research
2023;
12
(4)
:701-704
.
(28 April 2023)
PD-L1 expression on tumor cells as a potential predictive biomarker for patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy followed by durvalumab
Translational Cancer Research
2023;
12
(4)
:705-708
.
(28 April 2023)
In silico trials of combination immuno-radiation for unresectable hepatocellular carcinoma
Translational Cancer Research
2023;
12
(4)
:709-712
.
(28 April 2023)
Increased abscopal responses after radiation therapy for oligoprogressive patients receiving immune checkpoint inhibitors?
Translational Cancer Research
2023;
12
(4)
:713-716
.
(28 April 2023)
Original Article
An integrated bioinformatics analysis of the S100 in head and neck squamous cell carcinoma
Translational Cancer Research
2023;
12
(4)
:717-731
.
(28 April 2023)
Efficacy and safety of methylphenidate and ginseng in cancer-related fatigue: a network meta-analysis of randomized controlled trials
Translational Cancer Research
2023;
12
(4)
:732-742
.
(28 April 2023)
Ferula sinkiangensis against gastric cancer: a network pharmacology, molecular docking and cell experiment study
Translational Cancer Research
2023;
12
(4)
:743-764
.
(28 April 2023)
CT-based three-dimensional invasiveness analysis of adenocarcinoma presenting as pure ground-glass nodules
Translational Cancer Research
2023;
12
(4)
:765-773
.
(28 April 2023)
Bioinformatics identification of prognostic genes and potential interaction analysis in renal cell carcinoma
Translational Cancer Research
2023;
12
(4)
:774-783
.
(28 April 2023)
The influence of antibody CD166 on the treatment of tumor and the immunological mechanism in mice bearing oral squamous cell carcinoma
Translational Cancer Research
2023;
12
(4)
:784-792
.
(28 April 2023)
Nomogram for predicting preoperative axillary lymph node status in male breast carcinoma: a SEER population-based study
Translational Cancer Research
2023;
12
(4)
:793-803
.
(28 April 2023)
Establishment and validation of nomograms for predicting survival of lung invasive adenocarcinoma based on the level of pathological differentiation: a SEER cohort-based analysis
Translational Cancer Research
2023;
12
(4)
:804-827
.
(28 April 2023)
Methyl vanillate for inhibiting the proliferation, migration, and epithelial-mesenchymal transition of ovarian cancer cells via the ZEB2/Snail signaling pathway
Translational Cancer Research
2023;
12
(4)
:828-836
.
(28 April 2023)
Detection of EGFR mutations in early-stage lung adenocarcinoma by machine learning-based radiomics
Translational Cancer Research
2023;
12
(4)
:837-847
.
(28 April 2023)
The 100 most cited papers in nasopharyngeal carcinoma between 2000 and 2019: a bibliometric study
Translational Cancer Research
2023;
12
(4)
:848-858
.
(28 April 2023)
High expression of RTN4IP1 predicts adverse prognosis for patients with breast cancer
Translational Cancer Research
2023;
12
(4)
:859-872
.
(28 April 2023)
Multicenter, single-arm phase II study of modified carboplatin/nab-paclitaxel in untreated performance status 2 patients with advanced non-small cell lung cancer: TORG1426
Translational Cancer Research
2023;
12
(4)
:873-886
.
(28 April 2023)
Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
Translational Cancer Research
2023;
12
(4)
:887-903
.
(28 April 2023)
The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study
Translational Cancer Research
2023;
12
(4)
:904-912
.
(28 April 2023)
High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia
Translational Cancer Research
2023;
12
(4)
:913-927
.
(28 April 2023)
Comparing the cost-effectiveness of sintilimab + pemetrexed plus platinum and pemetrexed plus platinum alone as a first-line therapy for Chinese patients with nonsquamous non-small cell lung cancer
Translational Cancer Research
2023;
12
(4)
:928-938
.
(28 April 2023)
Characteristics and survival analysis of breast cancer survivors with metachronous double primary cancers: a retrospective cohort study
Translational Cancer Research
2023;
12
(4)
:939-948
.
(28 April 2023)
Integrated analysis of coexpression and a tumor-specific ceRNA network revealed a potential prognostic biomarker in breast cancer
Translational Cancer Research
2023;
12
(4)
:949-964
.
(28 April 2023)
Development and validation of a predictive nomogram for the specific mortality risk of luminal B breast cancer patients: a competing risk model based on real populations
Translational Cancer Research
2023;
12
(4)
:965-979
.
(28 April 2023)
Correlation of gene expression profiles to identify pancreatic cancer cell lines that best model primary human tumors
Translational Cancer Research
2023;
12
(4)
:980-991
.
(28 April 2023)
N6-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma
Translational Cancer Research
2023;
12
(4)
:992-1005
.
(28 April 2023)
Network pharmacology- and molecular docking-based investigation of the therapeutic potential and mechanism of daucosterol against multiple myeloma
Translational Cancer Research
2023;
12
(4)
:1006-1020
.
(28 April 2023)
Identification of GINS1 as a potential prognostic biomarker for sarcoma using bioinformatic analysis
Translational Cancer Research
2023;
12
(4)
:1021-1032
.
(28 April 2023)
Case Report
A case report of primary angiosarcoma of the breast
Translational Cancer Research
2023;
12
(4)
:1033-1040
.
(28 April 2023)
Effectiveness of tislelizumab when combined with etoposide and carboplatin in patients with SMARCA4-deficient undifferentiated thoracic tumor: a case report
Translational Cancer Research
2023;
12
(4)
:1041-1048
.
(28 April 2023)
Large rectal diverticulum in the setting of pelvic organ prolapse treated with robotic ventral mesh rectopexy: a case report
Translational Cancer Research
2023;
12
(4)
:1049-1053
.
(28 April 2023)
A case report of T-LGL leukemia-associated pure red cell aplasia harboring STAT3, TNFAIP3, and KMT2D mutation
Translational Cancer Research
2023;
12
(4)
:1054-1059
.
(28 April 2023)
Primary pulmonary artery chondrosarcoma: case report
Translational Cancer Research
2023;
12
(4)
:1060-1066
.
(28 April 2023)
